Prenetics Global (NASDAQ:PRE) CEO Danny Sheng Wu Yeung Buys 7,500 Shares of Stock

Prenetics Global Limited (NASDAQ:PRE) CEO Danny Sheng Wu Yeung acquired 7,500 shares of the company’s stock in a transaction dated Thursday, August 20th. The shares were bought at an average cost of $18.31 per share, with a total value of $137,325.00. Following the completion of the acquisition, the chief executive officer directly owned 95,235 shares in the company, valued at $1,743,752.85. The trade was a 8.55% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Danny Sheng Wu Yeung also recently made the following trade(s):

• On Monday, August 24th, Danny Sheng Wu Yeung bought 17,181 shares of Prenetics Global stock. The stock was purchased at an average cost of $21.23 per share, for a total transaction of $364,752.63.

Prenetics Global Stock Up 8.0%

PRE opened at $21.82 on Tuesday. The business’s fifty day simple moving average is $19.07 and its 200 day simple moving average is $18.90. Prenetics Global Limited has a 52 week low of $7.18 and a 52 week high of $23.63. The stock has a market cap of $368.19 million, a PE ratio of -5.25 and a beta of 0.26.

Prenetics Global (NASDAQ:PRE) last issued its quarterly earnings results on Wednesday, August 19th. The company reported ($0.53) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.84) by $0.31. Prenetics Global had a negative return on equity of 21.41% and a negative net margin of 47.43%.The firm had revenue of $46.49 million during the quarter, compared to analyst estimates of $49.85 million. As a group, equities analysts anticipate that Prenetics Global Limited will post -1.86 earnings per share for the current year.

Institutional Investors Weigh In On Prenetics Global

Hedge funds and other institutional investors have recently modified their holdings of the stock. Wells Fargo & Company MN purchased a new stake in shares of Prenetics Global in the 4th quarter worth approximately $47,000. State of Wyoming purchased a new position in Prenetics Global during the first quarter valued at $48,000. JPMorgan Chase & Co. bought a new stake in Prenetics Global in the third quarter worth $65,000. Operose Advisors LLC bought a new stake in Prenetics Global in the second quarter worth $129,000. Finally, Manatuck Hill Partners LLC purchased a new stake in shares of Prenetics Global in the fourth quarter worth $170,000. Institutional investors own 25.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on PRE shares. Benchmark upped their target price on Prenetics Global from $30.00 to $40.00 and gave the stock a “buy” rating in a research note on Wednesday, July 15th. Weiss Ratings reissued a “sell (d-)” rating on shares of Prenetics Global in a research note on Friday, July 17th. Finally, Wall Street Zen upgraded shares of Prenetics Global from a “sell” rating to a “hold” rating in a report on Saturday. Four analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $34.25.

Prenetics Global Company Profile

Prenetics Global (NASDAQ: PRE) is a molecular diagnostics and genetic testing company that delivers a broad range of laboratory and at-home testing solutions. The company’s core offerings include next-generation sequencing (NGS) panels for hereditary health risks, pharmacogenomic reports to guide medication choices, and comprehensive consumer DNA testing services. In addition to genetic insights, Prenetics provides infectious disease diagnostics—most notably real-time PCR testing for pathogens such as SARS-CoV-2—through an integrated platform that combines sample collection, laboratory processing and digital reporting.

Serving both business-to-consumer and business-to-business markets, Prenetics operates a network of laboratories and service centers across Asia Pacific, Europe, the Middle East and North America.